key: cord-0969494-oipau1js
authors: Mao, Quanfu; Chu, Sharon; Shapiro, Svetlana; Young, Lawrence; Russo, Melissa; De Paepe, Monique E.
title: Placental Sars-Cov-2 distribution correlates with level of tissue oxygenation in Covid-19-associated necrotizing histiocytic intervillositis/perivillous fibrin deposition
date: 2021-12-02
journal: Placenta
DOI: 10.1016/j.placenta.2021.12.002
sha: 752420ee3ee773dc279535d409b5ab2f6a86e687
doc_id: 969494
cord_uid: oipau1js

INTRODUCTION: Recent evidence supports the – rare – occurrence of vertical transplacental SARS-CoV-2 transmission. We previously determined that placental expression of angiotensin-converting enzyme 2 (ACE2), the SARS-CoV-2 receptor, and associated viral cell entry regulators is upregulated by hypoxia. In the present study, we utilized a clinically relevant model of SARS-CoV-2-associated chronic histiocytic intervillositis/massive perivillous fibrin deposition (CHIV/MPFVD) to test the hypothesis that placental hypoxia may facilitate placental SARS-CoV-2 infection. METHODS: We performed a comparative immunohistochemical and/or RNAscope in-situ hybridization analysis of carbonic anhydrase IX (CAIX, hypoxia marker), ACE2 and SARS-CoV-2 expression in free-floating versus fibrin-encased chorionic villi in a 20-weeks’ gestation placenta with SARS-CoV-2-associated CHIV/MPVFD. RESULTS: The levels of CAIX and ACE2 immunoreactivity were significantly higher in trophoblastic cells of fibrin-encased villi than in those of free-floating villi, consistent with hypoxia-induced ACE2 upregulation. SARS-CoV-2 showed a similar preferential localization to trophoblastic cells of fibrin-encased villi. DISCUSSION: The localization of SARS-CoV-2 to hypoxic, fibrin-encased villi in this placenta with CHIV/MPVFD suggests placental infection and, therefore, transplacental SARS-CoV-2 transmission may be promoted by hypoxic conditions, mediated by ACE2 and similar hypoxia-sensitive viral cell entry mechanisms. Understanding of a causative link between placental hypoxia and SARS-CoV-2 transmittability may potentially lead to the development of alternative strategies for prevention of intrauterine Covid-19 transmission.

The 2019 novel coronavirus, SARS-CoV-2, and the associated disease, COVID-19 1-3 , have 2 affected more than 180 million persons worldwide and resulted in more than four million deaths as 3 of July, 2021 [World Health Organization situation report] [Johns Hopkins COVID-19 Case 4 Tracker, https://coronavirus.jhu.edu/], creating an unrelenting public health threat. Like other 5 coronaviruses linked to epidemics, such as severe acute respiratory syndrome-related coronavirus 6 (SARS-CoV) 4 and Middle East respiratory syndrome coronavirus (MERS-CoV) 5 , SARS-CoV-2 7 primarily targets the respiratory tract 6 . 8

However, a growing number of suspected or confirmed intrauterine or intrapartum-acquired 9 neonatal SARS-CoV-2 infections have been reported, suggesting intrauterine vertical transmission 10 of SARS-CoV-2 from pregnant mother to placenta and/or fetus may be possible, albeit exceptional 11 [7] [8] [9] [10] [11] [12] [13] [14] [15] . Among these, several recent reports have described the occurrence of placental SARS-CoV- 2 12 infection in association with chronic histiocytic intervillositis (CHIV) with or without massive 13 perivillous fibrin deposition (MPVFD) [10] [11] [12] [13] [16] [17] [18] [19] [20] . In the vast majority of reported CHIV cases in 14 maternal COVID-19 infection, the virus was directly demonstrated within the syncytiotrophoblast 15 by either immunohistochemistry or in-situ hybridization 11, 13, [16] [17] [18] [19] 21 , supporting the hypothesis that 16 the placental inflammation may be related to the viral infection and may, in fact, represent a 17 characteristic form of SARS-CoV-2 placentitis 16 . By analogy, CHIV has been linked to other 18 infectious etiologies, such as malaria 22 Transmission of SARS-CoV-2 into and across the placenta critically depends on the availability and 1 functionality of its viral entry mechanisms in the placental syncytiotrophoblast layer. SARS-CoV-2 2 gains cellular entry by attachment of its surface-anchored spike protein (S) to the angiotensin-3 converting enzyme 2 (ACE2) receptor to trigger the initial attachment 26-28 . Further cell entry steps 4 include activation of the virus internalization process by host cell proteases, in particular the cell 5 surface protease, TMPRSS2 (transmembrane protease, serine 2), and lysosomal cathepsin proteases, 6

fusion of viral and cellular membranes, and endocytosis 28-32 . 7

In a previous study, centered on the twin anemia-polycythemia (TAPS) placenta as model of 8 intertwin differential placental oxygenation, we demonstrated that placental expression of ACE2, 9 localized mainly to (syncytio)trophoblastic cells, is upregulated in hypoxic conditions, associated 10 with increased expression of the main cell entry regulators, TMPRSS2 and cathepsin B 33 . In the 11 present study we tested the hypothesis that trophoblast hypoxia may facilitate placental SARS-12

CoV-2 transmission. To this end, we utilized a clinically relevant case of SARS-CoV-2-associated 13 CHIV/MPVFD to determine the spatial correlation between placental tissue oxygenation, ACE2 14 expression and SARS-CoV-2 distribution in vivo. 15 and were associated with extensive trophoblast necrosis ( Fig. 1 D) . The placenta further showed 23 scattered subchorionic and intervillous hemorrhages, adherent blood clot, and focal plasma cell CoV-2 protein distribution showed high regional variability, with a strong tendency to more intense negative control probe to assess non-specific background signals, was negative throughout the 3 placenta (Fig. 2 I) . 4 SARS-CoV-2 RNAscope in-situ hybridization of fetal lung, liver and gastrointestinal tract failed to 5 produce positive signals (not shown). However, the PPIB positive control was similarly negative in 6 these tissues, suggesting RNA degradation may have rendered the RNA scope technique unreliable 7 for detection of viral presence in the autolyzed tissues of this stillborn, and false negative ISH 8 results cannot be excluded. 9

To determine whether the regional variation of SARS-CoV-2 localization (i.e. higher viral load in 11 regions of perivillous fibrin deposition) correlated with similar regional variation in tissue in villi trapped in perivillous fibrin compared with non-encased, free-floating villi, consistent with 20 relative tissue hypoxia in areas of fibrin deposition ( Fig. 3 A-B) . 21

To determine whether the observed regional variability of tissue oxygenation correlated with 23 similar variability in availability of the SARS-CoV-2 cell entry axis, we studied protein expression 24 of ACE2, the cellular receptor of SARS-CoV-2, by immunohistochemistry. As shown in Fig. 3 C-E, 25 levels of ACE2 protein, immunolocalized to villous trophoblastic cells, were higher in hypoxic, 26 fibrin-encased villi than in free villi. In a prior study, we utilized the TAPS model to determine the effect of differential tissue 2 oxygenation on the expression of ACE2 and ACE2-related SARS-CoV-2 cell entry regulators in 3 the placenta 33 . In the present study we investigated whether hypoxia-induced ACE2 upregulation in 4 trophoblastic cells effectively promotes SARS-CoV-2 infection of these cells. To this end, we took 5 advantage of the regional variation in placental tissue oxygenation in SARS-CoV-2-associated 6 chronic histiocytic intervillositis/massive perivillous fibrin deposition (CHIV/MPVFD) to 7 determine the spatial correlation between placental tissue oxygenation and SARS-CoV-2 8 distribution. Using a combination of immunohistochemical/-fluorescence and RNA in-situ 9 hybridization methods, we established that SARS-CoV-2 preferentially localizes to fibrin-encased, 10 hypoxic trophoblastic cells. 11

The predilection of SARS-CoV-2 for hypoxic placental regions is likely mediated, at least in part, 

Novel Coronavirus from Patients with Pneumonia in China

Epidemiological and clinical characteristics of 99 cases of 2019 novel 6 coronavirus pneumonia in Wuhan, China: a descriptive study

Clinical features of patients infected with 2019 novel coronavirus in

Group SW: A novel coronavirus associated with severe acute respiratory syndrome

Isolation of a novel 17 coronavirus from a man with pneumonia in Saudi Arabia

Transmission of SARS-CoV-2: an update of current literature

Neonatal Early-Onset Infection With

SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate 5 immune genes

TMPRSS2 and COVID-7 19: Serendipity or Opportunity for Intervention? Cancer Discov 2020

Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus 12 origins and receptor binding

Veesler D: Structure, Function, and 14 Antigenicity of the SARS-CoV-2 Spike Glycoprotein

Increased placental expression of 16 angiotensin-converting enzyme 2, the receptor of SARS-CoV-2, associated with hypoxia in twin 17 anemia-polycythemia sequence (TAPS)

Reference values for singleton and twin placental 19 weights

Detection of SARS-CoV-2 in formalin-fixed 22 paraffin-embedded tissue sections using commercially available reagents

Hypoxia-inducible expression of 2 tumor-associated carbonic anhydrases

New insights into the physiological 4 role of carbonic anhydrase IX in tumour pH regulation

Myocardial infarction increases ACE2 expression in rat 7 and humans

Hypoxic regulation of angiotensin-converting

enzyme 2 and Mas receptor in human CD34(+) cells

Angiotensin converting enzyme versus 11 angiotensin converting enzyme-2 selectivity of MLN-4760 and DX600 in human and murine bone 12 marrow-derived cells

Epigenetic regulation of angiotensin-14 converting enzyme 2 (ACE2) by SIRT1 under conditions of cell energy stress

Effect of oxygen on the expression of renin-angiotensin 18 system components in a human trophoblast cell line

20 Consistent localization of SARS-CoV-2 spike glycoprotein and ACE2 over TMPRSS2 21 predominance in placental villi of 15 COVID-19 positive maternal-fetal dyads

We confirm that the manuscript has been read and approved by all named authors and that there are no other persons who satisfied the criteria for authorship but are not listed.We further confirm that any aspect of the work covered in this manuscript that has involved human patients has been conducted with the ethical approval of the institutional review board and that such approval is acknowledged within the manuscript.We understand that Monique De Paepe as Corresponding Author is the sole contact for the Editorial process. She is responsible for communicating with the other authors about progress, submissions of revisions and final approval of proofs.